IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10584097 B1

PDFFull Text
Date of Patent:
Mar. 10, 2020

Filed:

Sep. 20, 2019

Heterocyclic compound and use thereof

Applicant:

Takeda Pharmaceutical Company Limited, Chuo-ku, Osaka-shi, Osaka, JP;

Inventors:

Yuichi Kajita, Kanagawa, JP;

Yuhei Miyanohana, Kanagawa, JP;

Tatsuki Koike, Kanagawa, JP;

Kohei Takeuchi, Kanagawa, JP;

Yoshiteru Ito, Kanagawa, JP;

Norihito Tokunaga, Kanagawa, JP;

Takahiro Sugimoto, Kanagawa, JP;

Tohru Miyazaki, Kanagawa, JP;

Tsuneo Oda, Kanagawa, JP;

Yasutaka Hoashi, Kanagawa, JP;

Yasushi Hattori, Kanagawa, JP;

Keisuke Imamura, Kanagawa, JP;

Assignee:

Takeda Pharmaceutical Company Limited, Osaka, JP;

Attorney:

Foley & Lardner LLP

Primary Examiner:

Heidi Reese

Int. Cl.
CPC ...
C07D 211/56 (2006.01); C07D 405/06 (2006.01); C07D 205/04 (2006.01); C07D 207/14 (2006.01); C07D 401/06 (2006.01); C07D 401/10 (2006.01); C07D 401/14 (2006.01); C07D 403/06 (2006.01); C07D 405/10 (2006.01); C07D 405/12 (2006.01); C07D 413/06 (2006.01); C07D 417/06 (2006.01); C07D 417/14 (2006.01); C07D 211/36 (2006.01); A61P 25/00 (2006.01);
U.S. Cl.
CPC ...
C07D 211/56 (2013.01); A61P 25/00 (2018.01); C07D 205/04 (2013.01); C07D 207/14 (2013.01); C07D 211/36 (2013.01); C07D 401/06 (2013.01); C07D 401/10 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 405/06 (2013.01); C07D 405/10 (2013.01); C07D 405/12 (2013.01); C07D 413/06 (2013.01); C07D 417/06 (2013.01); C07D 417/14 (2013.01);
Abstract

The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.

Find Patent Forward Citations

Loading…